Prostatic Urethral Lift Vs Prostate Arterial Embolization: Novel Nonablative Strategies in the Management of Lower Urinary Tract Symptoms Secondary to Benign Prostate Hyperplasia

Urology

Volumn 87, Issue , 2016, Pages 11-17

  Jones, Patrick ^a   Rai, Bhavan Prasad ^b   Aboumarzouk, Omar M ^c   Somani, Bhaskar K ^d  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b LISTER HOSPITAL   (United Kingdom)

^c ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ARTIFICIAL EMBOLISM; COMORBIDITY; DYSURIA; HEMATURIA; HUMAN; LOCAL ANESTHESIA; LOWER URINARY TRACT SYMPTOM; MALE; NAUSEA; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATIC STENT; REVIEW; SEXUAL FUNCTION; TRANSURETHRAL RESECTION; ARTIFICIAL EMBOLIZATION; COMPLICATION; DISEASE MANAGEMENT; LOWER URINARY TRACT SYMPTOMS; PRACTICE GUIDELINE; PROCEDURES; PROSTATE; PROSTATIC HYPERPLASIA; SURGERY; URETHRA; UROLOGIC SURGERY; VASCULARIZATION;

DISEASE MANAGEMENT; EMBOLIZATION, THERAPEUTIC; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATE; PROSTATIC HYPERPLASIA; URETHRA; UROLOGIC SURGICAL PROCEDURES;

EID: 84959519691     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.10.005     Document Type: Review

References (42)

1. S. Kaplan The prostate urethral lift: will it be uplifting or downgraded as a treatment strategy for benign prostatic hyperplasia? Eur Urol 67 2015 714 715 10.1016/j.eururo.2014.12.013
2. B.K. Somani, N. Hacking, T. Bryant, and et al. Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH) BJU Int 114 2014 639 640
3. C.G. Roehrborn Pathology of benign prostatic hyperplasia Int J Impot Res 20 2008 S11 S18 10.1038/ijir.2008.55
4. K.T. McVary Clinical evaluation of benign prostatic hyperplasia Rev Urol 5 Suppl. 4 2003 S3 S11
5. F.M. Debruyne Alpha blockers: are all created equal? Urology 56 2000 20 22
6. F. Pinto, M. Racioppi, E. Sacco, and et al. Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia Arch Ital Urol Androl 81 2009 1 8
7. W.D. Steers 5alpha-reductase activity in the prostate Urology 58 2001 17 24
8. C.G. Roehrborn, P. Siami, J. Barkin, and et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study J Urol 179 2008 616 621
9. A.M. Traish, J. Hassani, A.T. Guay, and et al. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients J Sex Med 8 2008 872 884 10.1111/j.1743-6109.2010.02157.x
10. M. Marszalek, A. Ponholzer, M. Pusman, and et al. Transurethral resection of the prostate Eur Urol Suppl 8 2009 504 512
11. J. Rassweiler, D. Teber, R. Kuntz, and et al. Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention Eur Urol 50 2006 969 979
12. H. Hashim, and P. Abrahms Transurethral resection of the prostate for benign prostatic obstruction: will it remain the gold standard? Eur Urol 67 2015 1097 1098 10.1016/j.eururo.2014.12.022
13. A. Bachmann, A. Tubaro, N. Barber, and et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study J Urol 193 2015 570 578
14. E.A. Elzayat, E. Habib, and M.M. Elhilali Holmium laser enucleation of the prostate: a size-independent new 'gold standard" Urology Suppl 5 2005 108 113
15. T.R. Herrmann, E.N. Liatsikos, U. Nagele, and et al. EAU Guidelines Panel on Lasers T: EAU guidelines on laser technologies Eur Urol 61 2012 783 795
16. T.A. McNicholas, H. Woo, P.T. Chin, and et al. Minimally invasive prostatic urethral lift: surgical technique and multinational experience Eur Urol 64 2013 292 299
17. H. Woo, P.T. Chin, T.A. McNicholas, and et al. Safety and feasibility of the prostatic urethra lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) BJU Int 108 2011 82 88
18. C. Garcia, P.T. Chin, P. Rashid, and et al. Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia Prostate Int 3 2015 1 5 10.1016/j.prnil.2015.02.002
19. H. Woo, D. Bolton, E. Laborde, and et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia J Sex Med 9 2012 568 575
20. P.T. Chin, D. Bolton, D. Jack, and et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia Urology 79 2012 5 11
21. C.G. Roehrborn, S.N. Gange, N.D. Shore, and et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT study J Urol 190 2013 2161 2167
22. C.G. Roehrborn, S. Gange, N.D. Shore, and et al. Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. study Urol Pract 2 2015 26 32
23. A.L. Cantwell, W.K. Bogache, S.F. Richardson, and et al. Multicentre prospective crossover study of the prostatic urethral lift for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia BJU Int 113 2014 615 622
24. J. Sønksen, N.J. Barber, M.J. Speakman, and et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study Eur Urol 68 2015 643 652 10.1016/j.eururo.2015.04.024
25. K.T. McVary, S.N. Gange, N.D. Shore, and et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift J Sex Med 11 2014 279 287
26. A.A. Antunes, F.C. Carnevale, J.M. da Motta-Leal-Filho, and et al. Clinical, laboratorial and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia: a prospective single center pilot study Cardiovasc Intervent Radiol 36 2013 978 986
27. J.M. Pisco, H.R. Tinto, L.C. Pinheiro, and et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow up Eur Radiol 23 2013 2561 2572
28. D. Kurbatov, G.I. Russo, A. Lepetukhin, and et al. Prostatic artery embolization for prostate volume greater than 80 cm(3): results from a single-center prospective study Urology 84 2014 400 404
29. Gao Y.A., Huang Y., Zhang R., and et al. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate-a prospective, randomized, and controlled clinical trial Radiology 270 2014 920 928
30. Wang M., Guo L., Duan F., and et al. Prostatic arterial embolization for the treatment of LUTS due to benign prostatic hyperplasia: a comparative study of medium and large size prostates BJU Int 2015 10.1111/bju.13147
31. J. Martins Pisco, J. Pereira, H. Rio Tinto, and et al. How to perform prostatic arterial embolization Tech Vasc Interv Radiol 15 2012 286 289
32. V.F. Nadalini, N. Positano, G.P. Bruttiono, and et al. Therapeutic occlusion of the hypogastric arteries with isobutyl-2-cyanoacrylate in vesical and prostatic cancer Radiol Med (Torino) 67 1981 61 66
33. J.S. DeMeritt, F.F. Elmasri, M.P. Esposito, and et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization J Vasc Interv Radiol 11 2000 767 770
34. J.P. Dyer, K.A. Johnson, T. Bryant, and et al. Short-term results of the first UK prospective study of prostate artery embolisation (PAE) for benign prostatic enlargement in patients with urodynamically proven bladder outflow obstruction Eur Urol Suppl 14 2015 e569
35. J.P. McWilliams, M.D. Kuo, S.C. Rose, and et al. Society of Interventional Radiology Position Statement: prostate artery embolization for treatment of benign disease of the prostate J Vasc Interv Radiol 25 2014 1349 1351
36. C. Carnevale, J.M. da Motta-Leal-Filho, A.A. Antunes, and et al. Quality of life and clinical symptom improvement support prostatic arterial embolization for patients with acute urinary retention caused by benign prostatic hyperplasia J Vasc Interv Radiol 24 2013 535 542
37. A.M. Moreira, C.F. Marques, A.A. Antunes, and et al. Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature Cardiovasc Intervent Radiol 36 2013 1690 1694
38. Yang Z., Wang X., and Liu T. Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up Urology 81 2013 396 400
39. M. Perera, M.J. Roberts, S.A.R. Doi, and et al. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis Eur Urol 67 2015 704 713
40. N.D. Shore, S. Freedman, S. Gange, and et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift Can J Urol 21 2014 7094 7101
41. C. Mamoulakis, I. Efthimiou, S. Kazoulis, and et al. The modified Clavien classification system. A standardized platform for reporting complications in transurethral resection of the prostate World J Urol 29 2011 205 210
42. D. Moher, A. Jones, and L. Lepage Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation JAMA 285 2001 1992